Results 31 to 40 of about 1,772,507 (392)
Advances in enteric disease vaccines: from innovation to implementation [PDF]
, 2014 The Seventh International Conference on Vaccines for Enteric Diseases Bangkok, Thailand, 6–8 November 2013 Hosting 222 participants from more than 25 countries, the Seventh International Conference on Vaccines for Enteric Diseases (VED 2013) displayed ...
Parker, EPK
core +1 more source
MMWR Recommendations and Reports, 2022 Summary This report updates the 2021–22 recommendations of the Advisory Committee on Immunization Practices (ACIP) concerning the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2021;70[No. RR-5]:1–24).
L. Grohskopf +7 more
semanticscholar +1 more source
The Hajj 2019 Vaccine Requirements and Possible New Challenges [PDF]
, 2019 Each year millions of pilgrims perform the annual Hajj from more than 180 countries around the world. This is one of the largest mass gathering events and may result in the occurrence and spread of infectious diseases.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core +1 more source
Journal of the American Medical Association (JAMA), 2021 Importance Although effective vaccines against COVID-19 have been developed, additional vaccines are still needed. Objective To evaluate the efficacy and adverse events of 2 inactivated COVID-19 vaccines.
N. A. Al Kaabi +40 more
semanticscholar +1 more source
DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease [PDF]
, 2016 Current influenza vaccines are effective but imperfect, failing to cover against emerging strains of virus and requiring seasonal administration to protect against new strains. A key step to improving influenza vaccines is to improve our understanding of
Bogen, B +8 more
core +8 more sources
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Nature Reviews Clinical Oncology, 2021 Within the past decade, the field of immunotherapy has revolutionized the treatment of many cancers with the development and regulatory approval of various immune-checkpoint inhibitors and chimeric antigen receptor T cell therapies in diverse indications.
Eryn Blass, P. Ott
semanticscholar +1 more source
Acknowledgement to Reviewers of Vaccines in 2015
Vaccines, 2016 The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2015. [...]
Vaccines Editorial Office
doaj +1 more source
npj Vaccines, 2023 Since the original outbreak of the SARS-CoV-2 virus, several rapidly spreading SARS-CoV-2 variants of concern (VOC) have emerged. Here, we show that a single dose of Ad26.COV2.S (based on the Wuhan-Hu-1 spike variant) protects against the Gamma and Delta
Maarten Swart +32 more
doaj +1 more source
Acknowledgement to Reviewers of Vaccines in 2013
Vaccines, 2014 The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Vaccines Editorial Office
doaj +1 more source
Vaccines, 2021 The current study systematically reviewed, summarized and meta-analyzed the clinical features of the vaccines in clinical trials to provide a better estimate of their efficacy, side effects and immunogenicity.
A. Pormohammad +5 more
semanticscholar +1 more source